Kewaunee Scientific Corporation
KEQU
$36.68
$0.110.30%
NASDAQ
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 17.27% | 30.78% | 43.02% | 30.09% | 18.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.27% | 30.78% | 43.02% | 30.09% | 18.02% |
| Cost of Revenue | 17.45% | 27.37% | 38.16% | 24.18% | 13.12% |
| Gross Profit | 16.82% | 39.98% | 56.41% | 46.89% | 32.29% |
| SG&A Expenses | 24.71% | 41.53% | 72.22% | 60.55% | 50.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.11% | 30.45% | 45.00% | 31.19% | 19.98% |
| Operating Income | -5.88% | 35.30% | 20.69% | 18.09% | -2.01% |
| Income Before Tax | -7.12% | 79.52% | 40.76% | 34.09% | 12.70% |
| Income Tax Expenses | 2.06% | 149.89% | 148.70% | 156.77% | 153.92% |
| Earnings from Continuing Operations | -9.65% | -34.21% | -36.58% | -33.42% | -39.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -375.84% | -173.50% | -31.34% | 35.39% | 41.45% |
| Net Income | -15.67% | -36.98% | -37.37% | -33.39% | -39.18% |
| EBIT | -5.88% | 35.30% | 20.69% | 18.09% | -2.01% |
| EBITDA | 3.40% | 38.52% | 31.20% | 25.08% | 4.66% |
| EPS Basic | -15.71% | -36.89% | -37.24% | -33.18% | -38.98% |
| Normalized Basic EPS | -14.69% | 19.82% | 3.40% | 2.54% | -12.35% |
| EPS Diluted | -15.95% | -37.04% | -37.55% | -33.69% | -39.67% |
| Normalized Diluted EPS | -14.77% | 19.41% | 2.67% | 1.23% | -14.00% |
| Average Basic Shares Outstanding | 0.02% | -0.12% | -0.25% | -0.47% | -0.58% |
| Average Diluted Shares Outstanding | 0.12% | 0.08% | 0.43% | 0.66% | 1.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |